Pacific Biosciences of California | 8-K: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Schedul
Apr 16 08:09 ET
Pacific Biosciences of California | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 15 08:18 ET
Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Apr 11 17:06 ET
Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Apr 11 17:06 ET
Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Apr 11 17:06 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director ORDONEZ KATHY
Mar 19 16:27 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director Meline David W
Mar 6 17:40 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Farmer Michele
Mar 6 17:36 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Van Oene Mark
Mar 6 17:31 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Kim Susan G.
Mar 6 17:26 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer HENRY CHRISTIAN O
Mar 6 17:16 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director MOHR MARSHALL
Mar 5 16:33 ET
Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 18:36 ET
Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 18:27 ET
Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:41 ET
Pacific Biosciences of California | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 29 13:58 ET
Pacific Biosciences of California | 10-K: Annual report
Feb 28 22:40 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer HENRY CHRISTIAN O
Feb 26 17:01 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Van Oene Mark
Feb 26 16:57 ET
Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Kim Susan G.
Feb 26 16:44 ET
No Data
No Data